Medicare Program; Meeting of the Advisory Board on the Demonstration of a Bundled Case-Mix Adjusted Payment System for End-Stage Renal Disease Services-May 24, 2005, 22320-22321 [05-8386]
Download as PDF
<![CDATA[
22320
Federal Register / Vol. 70, No. 82 / Friday, April 29, 2005 / Notices
for the State of Washington to publish
corresponding changes to the
Washington State Medical Test Site
Rules, which were effective March 19,
2005.
VIII. Collection of Information
Requirements
This document does not impose
information collection, and
recordkeeping requirements, which are
subject to the Paperwork Reduction Act
of 1995 (PRA) (44 U.S.C. 35).
Consequently, it need not be reviewed
by the Office of Management and
Budget under the authority of the PRA.
VIX. Regulatory Impact Statement
This notice announces the
continuance of the exemption of
laboratories licensed by the State of
Washington from the requirements of
the Clinical Laboratory Improvement
Amendments of 1988 (CLIA). The State
has established that the quality of
laboratory services required under its
Laboratory licensure program continues
to be equal or more stringent than those
required by the CLIA program.
Washington also has established that it
has a comparable program to monitor
and evaluate compliance with its
laboratory licensure program
requirements. The effect of the
continued exemption from CLIA
requirements is that laboratories will
remain under State, rather than Federal,
regulation, with no discernible
difference in the operations of the
programs. Consequently, we anticipate
that our continued approval of
Washington’s CLIA exemption will not
affect the laboratories or the quality and
availability of services provided.
We have examined the impact of this
notice as required by Executive Order
12866 (September 1993, Regulatory
Planning and Review), the Regulatory
Flexibility Act (RFA) (September 19,
1980, Pub. L. 96–354), section 1102(b) of
the Social Security Act, the Unfunded
Mandates Reform Act of 1995 (Pub. L.
104–4), and Executive Order 13132.
Executive Order 12866 directs
agencies to assess all costs and benefits
of available regulatory alternatives and,
if regulation is necessary, to select
regulatory approaches that maximize
net benefits (including potential
economic, environmental, public health
and safety effects, distributive impacts,
and equity). A regulatory impact
analysis (RIA) must be prepared for
major rules with economically
significant effects ($100 million or more
in any 1 year). This notice does not
reach the economic threshold and thus
is not considered a major rule.
VerDate jul<14>2003
16:04 Apr 28, 2005
Jkt 205001
The RFA requires agencies to analyze
options for regulatory relief of small
businesses. For purposes of the RFA,
small entities include small businesses,
nonprofit organizations, and
government agencies. Most hospitals
and most other providers and suppliers
are small entities, either by nonprofit
status or by having revenues of $6
million to $29 million in any 1 year.
Individuals and States are not included
in the definition of a small entity. We
are not preparing an analysis for the
RFA because we have determined that
this notice will not have a significant
economic impact on a substantial
number of small entities.
In addition, section 1102(b) of the Act
requires us to prepare a regulatory
impact analysis if a notice may have a
significant impact on the operations of
a substantial number of small rural
hospitals. This analysis must conform to
the provisions of section 604 of the
RFA. For purposes of section 1102(b) of
the Act, we define a small rural hospital
as a hospital that is located outside of
a Metropolitan Statistical Area and has
fewer than 100 beds. We are not
preparing an analysis for section 1102(b)
of the Act because we have determined
that this notice will not have a
significant impact on the operations of
a substantial number of small rural
hospitals.
Section 202 of the Unfunded
Mandates Reform Act of 1995 also
requires that agencies assess anticipated
costs and benefits before issuing any
rule that may result in expenditure in
any 1 year by State, local, or tribal
governments, in the aggregate, or by the
private sector, of $110 million. This
notice will have no consequential effect
on the governments mentioned or on the
private sector.
Executive Order 13132 establishes
certain requirements that an agency
must meet when it promulgates a
proposed rule (and subsequent final
rule) that imposes substantial direct
requirement costs on State and local
governments, preempts State law, or
otherwise has Federalism implications.
Since this regulation does not impose
any costs on State or local governments,
the requirements of E.O. 13132 are not
applicable.
In accordance with the provisions of
Executive Order 12866, this regulation
was not reviewed by the Office of
Management and Budget.
Authority: Section 353(p) of the Public
Health Service Act (42 U.S.C. 263a).
(Catalog of Federal Domestic Assistance
Program No. 93.778, Medical Assistance
Program; No. 93.773 Medicare—Hospital
Insurance Program; and No. 93.774,
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
Medicare—Supplementary Medical
Insurance Program)
Dated: April 8, 2005.
Mark B. McClellan,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. 05–8286 Filed 4–22–05; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–5033–N4]
Medicare Program; Meeting of the
Advisory Board on the Demonstration
of a Bundled Case-Mix Adjusted
Payment System for End-Stage Renal
Disease Services—May 24, 2005
Centers for Medicare &
Medicaid Services (CMS),HHS.
ACTION: Notice.
AGENCY:
SUMMARY: This notice announces the
second public meeting of the Advisory
Board on the Demonstration of a
Bundled Case-Mix Adjusted Payment
System for End-Stage Renal Disease
(ESRD) Services. Notice of this meeting
is required by the Federal Advisory
Committee Act (5 U.S.C. App. 2, section
10(a)(1) and (a)(2)). The Advisory Board
will provide advice and
recommendations with respect to the
establishment and operation of the
demonstration mandated by section
623(e) of the Medicare Prescription
Drug, Improvement, and Modernization
Act of 2003.
DATES: The meeting is on May 24, 2005
from 9 a.m. to 5 p.m., eastern standard
time.
Special Accomodations: Persons
attending the meeting, who are hearing
or visually impaired, or have a
condition that requires special
assistance or accommodations, are
asked to notify Pamela Kelly by May 17,
2005 by e-mail at
ESRDAdvisoryBoard@cms.hhs.gov or by
telephone at (410) 786–2461.
ADDRESSES: The meeting will be held at
the Holiday Inn—BWI Airport, 890
Elkridge Landing Rd., Linthicum, MD
21090.
Attendance is limited to the space
available, so seating will be on a first
come, first served basis.
Web site: Up-to-date information on
this meeting is located at https://
www.cms.hhs.gov/faca/esrd.
Hotline: Up-to-date information on
this meeting is located on the CMS
Advisory Committee Hotline at 1 (877)
E:\FR\FM\29APN1.SGM
29APN1
Federal Register / Vol. 70, No. 82 / Friday, April 29, 2005 / Notices
449–5659 (toll free) or in the Baltimore
area at (410) 786–9379.
FOR FURTHER INFORMATION CONTACT:
Pamela Kelly by e-mail at
ESRDAdvisoryBoard@cms.hhs.gov or
telephone at (410) 786–2461.
SUPPLEMENTARY INFORMATION: On June 2,
2004, we published a Federal Register
notice requesting nominations for
individuals to serve on the Advisory
Board on the Demonstration of a
Bundled Case-Mix Adjusted Payment
System for End-Stage Renal Disease
(ESRD) Services. The June 2, 2004
notice also announced the
establishment of the Advisory Board
and the signing by the Secretary on May
11, 2004 of the charter establishing the
Advisory Board. On January 28, 2005,
we published a Federal Register notice
announcing the appointment of eleven
individuals to serve as members of the
Advisory Board on the Demonstration of
a Bundled Case-Mix Adjusted Payment
System for ESRD Services, including
one individual to serve as cochairperson, and one additional cochairperson, who is employed by CMS.
The first public meeting of the Advisory
Board was held on February 16, 2005.
The original meeting scheduled for
April 13, 2005 was cancelled. This
notice announces the second public
meeting of this Advisory Board.
II. Procedure and Agenda of the
Advisory Board Meeting
This meeting is open to the public.
The Advisory Board will hear
background presentations from CMS.
The Advisory Board will then deliberate
openly on the general topic and will
make recommendations on specific
topics for future meetings. The Advisory
Board will also allow at least a 30minute open public session. Interested
parties may speak or ask questions
during the public comment period.
Comments may be limited by the time
available. Written questions should be
submitted by May 17, 2005 to
ESRDAdvisoryBoard@cms.hhs.gov.
Parties may also submit written
comments following the meeting to the
contact listed under the FOR FURTHER
INFORMATION CONTACT section of this
notice.
I. Topics of the Advisory Board Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
The Advisory Board on the
Demonstration of a Bundled Case-Mix
Adjusted Payment System for ESRD
Services will study and make
recommendations on the following
issues:
• The drugs, biologicals, and clinical
laboratory tests to be bundled into the
demonstration payment rates.
• The method and approach to be
used for the patient characteristics to be
included in the fully case-mix adjusted
demonstration payment system.
• The manner in which payment for
bundled services provided by nondemonstration providers should be
handled for beneficiaries participating
in the demonstration.
• The feasibility of providing
financial incentives and penalties to
organizations operating under the
demonstration that meet or fail to meet
applicable quality standards.
• The specific quality standards to be
used.
• The feasibility of using disease
management techniques to improve
quality and patient satisfaction and
reduce costs of care for the beneficiaries
participating in the demonstration.
• The selection criteria for
demonstration organizations.
VerDate jul<14>2003
16:04 Apr 28, 2005
Jkt 205001
Authority: 5 U.S.C. App. 2, section 10(a).
(Catalog of Federal Domestic Assistance
Program No. 93.774, Medicare—
Supplementary Medical Insurance Program)
Dated: April 21, 2005.
Mark B. McClellan,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. 05–8386 Filed 4–28–05; 8:45 am]
BILLING CODE 4120–01–U
Centers for Medicare & Medicaid
Services
[CMS–1314–N]
Medicare Program; Meeting of the
Practicing Physicians Advisory
Council, May 23, 2005
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
SUMMARY: In accordance with section
10(a) of the Federal Advisory Committee
Act, this notice announces a meeting of
the Practicing Physicians Advisory
Council (the Council). The Council will
be meeting to discuss certain proposed
changes in regulations and carrier
manual instructions related to
physicians’ services, as identified by the
Secretary of the Department of Health
and Human Services (the Secretary).
This meeting is open to the public.
DATES: The meeting is scheduled for
Monday, May 23, 2005, from 8:30 a.m.
until 5 p.m. e.d.t.
ADDRESSES: The meeting will be held in
Room 705A, 7th floor, in the Hubert H.
Humphrey Building, 200 Independence
Avenue, SW., Washington, DC 20201.
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
22321
Meeting Registration: Persons wishing
to attend this meeting must contact the
Designated Federal Official (DFO) by
email at PPAC@cms.hhs.gov at least 72
hours in advance of the meeting to
register. Persons not registered in
advance will not be permitted into the
Hubert H. Humphrey Building and will
not be permitted to attend the Council
meeting. Persons attending the meeting
will be required to show a photographic
identification, preferably a valid driver’s
license, before entering the building.
FOR FURTHER INFORMATION CONTACT:
Kelly Buchanon, Designated Federal
Official, Practicing Physicians Advisory
Council, 7500 Security Blvd., Mail Stop
C4–11–27, Baltimore, MD, 21244–1850,
telephone (410) 786–6132, or e-mail
PPAC@cms.hhs.gov. News media
representatives must contact the CMS
Press Office, (202) 690–6145. Please
refer to the CMS Advisory Committees
Information Line (1–877–449–5659 toll
free) ((410) 786–9379 local) or the
Internet at https://www.cms.hhs.gov/
faca/ppac/default.asp for additional
information and updates on committee
activities.
SUPPLEMENTARY INFORMATION: The
Secretary is mandated by section
1868(a) of the Social Security Act (the
Act) to appoint a Practicing Physicians
Advisory Council (the Council) based
on nominations submitted by medical
organizations representing physicians.
The Council meets quarterly to discuss
certain proposed changes in regulations
and carrier manual instructions related
to physicians’ services, as identified by
the Secretary. To the extent feasible and
consistent with statutory deadlines, the
consultation must occur before
publication of the proposed changes.
The Council submits an annual report
on its recommendations to the Secretary
and the Administrator of the Centers for
Medicare & Medicaid Services not later
than December 31 of each year.
The Council consists of 15 physicians,
each of whom must have submitted at
least 250 claims for physicians’ services
under Medicare in the previous year.
Members of the Council include both
participating and nonparticipating
physicians, and physicians practicing in
rural and underserved urban areas. At
least 11 members of the Council must be
physicians as described in section
1861(r)(1) of the Act; that is, Statelicensed doctors of medicine or
osteopathy. The remaining 4 members
may include dentists, podiatrists,
optometrists and chiropractors.
Members serve for overlapping 4-year
terms; terms of more than 2 years are
contingent upon the renewal of the
Council by appropriate action prior to
E:\FR\FM\29APN1.SGM
29APN1
]]>Agencies
[Federal Register Volume 70, Number 82 (Friday, April 29, 2005)]
[Notices]
[Pages 22320-22321]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-8386]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-5033-N4]
Medicare Program; Meeting of the Advisory Board on the
Demonstration of a Bundled Case-Mix Adjusted Payment System for End-
Stage Renal Disease Services--May 24, 2005
AGENCY: Centers for Medicare & Medicaid Services (CMS),HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the second public meeting of the
Advisory Board on the Demonstration of a Bundled Case-Mix Adjusted
Payment System for End-Stage Renal Disease (ESRD) Services. Notice of
this meeting is required by the Federal Advisory Committee Act (5
U.S.C. App. 2, section 10(a)(1) and (a)(2)). The Advisory Board will
provide advice and recommendations with respect to the establishment
and operation of the demonstration mandated by section 623(e) of the
Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
DATES: The meeting is on May 24, 2005 from 9 a.m. to 5 p.m., eastern
standard time.
Special Accomodations: Persons attending the meeting, who are
hearing or visually impaired, or have a condition that requires special
assistance or accommodations, are asked to notify Pamela Kelly by May
17, 2005 by e-mail at ESRDAdvisoryBoard@cms.hhs.gov or by telephone at
(410) 786-2461.
ADDRESSES: The meeting will be held at the Holiday Inn--BWI Airport,
890 Elkridge Landing Rd., Linthicum, MD 21090.
Attendance is limited to the space available, so seating will be on
a first come, first served basis.
Web site: Up-to-date information on this meeting is located at
https://www.cms.hhs.gov/faca/esrd.
Hotline: Up-to-date information on this meeting is located on the
CMS Advisory Committee Hotline at 1 (877)
[[Page 22321]]
449-5659 (toll free) or in the Baltimore area at (410) 786-9379.
FOR FURTHER INFORMATION CONTACT: Pamela Kelly by e-mail at
ESRDAdvisoryBoard@cms.hhs.gov or telephone at (410) 786-2461.
SUPPLEMENTARY INFORMATION: On June 2, 2004, we published a Federal
Register notice requesting nominations for individuals to serve on the
Advisory Board on the Demonstration of a Bundled Case-Mix Adjusted
Payment System for End-Stage Renal Disease (ESRD) Services. The June 2,
2004 notice also announced the establishment of the Advisory Board and
the signing by the Secretary on May 11, 2004 of the charter
establishing the Advisory Board. On January 28, 2005, we published a
Federal Register notice announcing the appointment of eleven
individuals to serve as members of the Advisory Board on the
Demonstration of a Bundled Case-Mix Adjusted Payment System for ESRD
Services, including one individual to serve as co-chairperson, and one
additional co-chairperson, who is employed by CMS. The first public
meeting of the Advisory Board was held on February 16, 2005. The
original meeting scheduled for April 13, 2005 was cancelled. This
notice announces the second public meeting of this Advisory Board.
I. Topics of the Advisory Board Meeting
The Advisory Board on the Demonstration of a Bundled Case-Mix
Adjusted Payment System for ESRD Services will study and make
recommendations on the following issues:
The drugs, biologicals, and clinical laboratory tests to
be bundled into the demonstration payment rates.
The method and approach to be used for the patient
characteristics to be included in the fully case-mix adjusted
demonstration payment system.
The manner in which payment for bundled services provided
by non-demonstration providers should be handled for beneficiaries
participating in the demonstration.
The feasibility of providing financial incentives and
penalties to organizations operating under the demonstration that meet
or fail to meet applicable quality standards.
The specific quality standards to be used.
The feasibility of using disease management techniques to
improve quality and patient satisfaction and reduce costs of care for
the beneficiaries participating in the demonstration.
The selection criteria for demonstration organizations.
II. Procedure and Agenda of the Advisory Board Meeting
This meeting is open to the public. The Advisory Board will hear
background presentations from CMS. The Advisory Board will then
deliberate openly on the general topic and will make recommendations on
specific topics for future meetings. The Advisory Board will also allow
at least a 30-minute open public session. Interested parties may speak
or ask questions during the public comment period. Comments may be
limited by the time available. Written questions should be submitted by
May 17, 2005 to ESRDAdvisoryBoard@cms.hhs.gov. Parties may also submit
written comments following the meeting to the contact listed under the
FOR FURTHER INFORMATION CONTACT section of this notice.
Authority: 5 U.S.C. App. 2, section 10(a). (Catalog of Federal
Domestic Assistance Program No. 93.774, Medicare--Supplementary
Medical Insurance Program)
Dated: April 21, 2005.
Mark B. McClellan,
Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 05-8386 Filed 4-28-05; 8:45 am]
BILLING CODE 4120-01-U
